data_2pjh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pjh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.63 0.253 . . . . 13.35 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.37 130.4 56.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 11.5 111.02 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -122.16 119.04 30.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.23 -0.441 . . . . 10.07 110.442 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.99 86.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.306 0.574 . . . . 7.9500000000000002 110.326 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -115.2 29.6 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.904 -0.589 . . . . 7.8099999999999996 110.649 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -56.66 138.1 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.792 -0.64 . . . . 4.4000000000000004 111.377 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 147.76 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.237 -0.438 . . . . 6.6500000000000004 110.501 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 6.8 m -111.97 137.74 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 5.5899999999999999 110.624 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.954 HE21 ' HH ' ' B' ' 110' ' ' TYR . 22.3 mt-30 -85.55 97.7 10.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.888 0.375 . . . . 7.1500000000000004 110.669 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -98.98 160.25 28.18 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.408 -0.59 . . . . 9.1099999999999994 109.408 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.68 -26.3 55.21 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.659 2.239 . . . . 11.85 112.386 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.04 -41.65 14.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.177 -0.465 . . . . 12.56 110.725 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.48 ' CA ' ' HA ' ' B' ' 109' ' ' LYS . . . 178.53 177.8 47.44 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.741 -0.743 . . . . 10.109999999999999 112.749 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 3.9 t -104.4 98.71 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.517 -0.549 . . . . 8.6300000000000008 109.517 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -114.91 166.94 11.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.243 0.544 . . . . 10.93 112.215 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -78.22 111.32 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 9.1300000000000008 110.527 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.43 154.87 5.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.856 -0.611 . . . . 6.7800000000000002 110.407 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.4 92.89 2.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.99 0.424 . . . . 9.0 110.138 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.67 158.73 26.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 7.2300000000000004 110.793 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.99 -176.46 3.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 8.9000000000000004 110.174 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.12 -38.3 85.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 12.66 110.32 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -138.95 134.83 33.67 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.027 -0.533 . . . . 11.859999999999999 110.798 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -168.87 150.71 4.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 7.0899999999999999 109.872 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -97.45 177.51 5.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.8 0.333 . . . . 8.0999999999999996 111.566 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.36 85.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.997 -0.547 . . . . 5.9000000000000004 110.819 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.72 78.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 5.8399999999999999 110.789 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.1 m -66.95 -41.18 87.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.002 -0.545 . . . . 5.9800000000000004 110.383 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.74 -41.12 68.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.988 -0.551 . . . . 3.6000000000000001 110.588 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 mt -60.19 -33.76 72.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 4.7699999999999996 110.282 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.64 -33.42 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 7.3300000000000001 110.37 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 28' ' ' THR . 98.4 mttt -66.84 -52.5 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 5.7000000000000002 110.833 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.84 -22.29 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 5.9900000000000002 110.901 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 39' ' ' PHE . . . -70.16 -20.95 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 6.8600000000000003 110.927 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -108.17 -43.5 4.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.078 -0.51 . . . . 8.3599999999999994 110.832 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -65.74 -47.8 74.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 8.8300000000000001 111.673 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.24 -18.92 15.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.161 0.505 . . . . 9.0700000000000003 110.467 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.86 25.44 58.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.812 -0.709 . . . . 8.9299999999999997 111.972 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.446 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.5 m-85 -82.36 170.46 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.895 -0.409 . . . . 9.3599999999999994 109.895 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -106.05 147.57 28.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.919 -0.4 . . . . 8.0500000000000007 109.919 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -62.87 -26.57 68.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 5.8200000000000003 111.243 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -95.51 12.02 30.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 8.2799999999999994 110.97 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.02 -47.83 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.888 -0.672 . . . . 8.4900000000000002 112.232 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -60.75 123.89 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 6.9500000000000002 110.601 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -107.83 136.79 46.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.009 -0.542 . . . . 8.4900000000000002 110.364 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.99 122.96 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 6.5099999999999998 110.776 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -133.57 137.08 45.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.717 -0.475 . . . . 11.109999999999999 109.717 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 9.4 pt -120.4 32.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.444 -0.343 . . . . 7.2999999999999998 111.887 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.09 169.03 23.96 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.363 -0.236 . . . . 10.15 110.363 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 24.6 ptt85 -81.57 -151.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 10.460000000000001 110.21 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 14.7 m120 68.08 51.95 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 12.789999999999999 109.774 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' N ' ' HB2' ' B' ' 141' ' ' GLU . 53.2 tttt -53.51 -39.73 64.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.081 -0.963 . . . . 11.81 112.258 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.75 -25.52 62.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 15.109999999999999 110.774 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 58' ' ' ALA . . . -80.14 -8.53 87.54 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.855 -0.611 . . . . 13.99 111.928 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.424 ' HA ' ' OG ' ' A' ' 59' ' ' SER . 36.1 mt-10 -72.32 -19.77 61.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.019 0.437 . . . . 12.119999999999999 110.352 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 mt -75.25 94.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.76 -0.655 . . . . 14.77 111.399 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m 70.73 -46.1 0.62 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.204 0.816 . . . . 15.890000000000001 113.204 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.428 ' HB2' ' O ' ' A' ' 54' ' ' GLY . . . -59.34 -23.41 62.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.676 0.621 . . . . 15.19 112.676 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.424 ' OG ' ' HA ' ' A' ' 55' ' ' GLU . 64.9 m -93.4 91.45 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.916 0.389 . . . . 12.9 110.649 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.91 18.4 17.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 13.960000000000001 110.475 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.9 160.53 30.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 12.17 110.848 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.39 127.76 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.553 -0.294 . . . . 13.869999999999999 110.607 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.19 15.09 2.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 8.9399999999999995 111.063 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HB3' ' H ' ' A' ' 65' ' ' HIS . 69.5 mt -84.55 -151.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 11.07 110.44 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.402 ' H ' ' HB3' ' A' ' 64' ' ' LEU . 30.9 p-80 -66.8 -8.55 29.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.571 0.224 . . . . 14.359999999999999 111.486 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.75 -50.7 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 12.84 110.811 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 16.7 mt -80.25 -24.17 40.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 10.779999999999999 111.574 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mttm 63.93 91.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.427 0.454 . . . . 14.01 111.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 46.9 mt -86.27 129.36 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.055 -0.52 . . . . 8.8900000000000006 109.966 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -81.02 166.37 20.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 10.59 110.664 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -75.91 77.16 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.143 0.497 . . . . 7.3399999999999999 110.408 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.93 30.86 0.85 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.709 -0.678 . . . . 5.5800000000000001 112.262 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 134.94 52.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.663 -0.495 . . . . 5.5300000000000002 109.663 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mt -76.78 133.81 39.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 5.7599999999999998 111.042 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -90.49 111.77 23.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 4.7300000000000004 109.998 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -83.01 101.23 10.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.06 -0.518 . . . . 10.02 110.002 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 25.4 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.584 -0.722 . . . . 8.4199999999999999 110.367 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.316 -0.253 . . . . 10.720000000000001 110.316 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 70.3 99.16 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.753 -0.658 . . . . 9.4600000000000009 110.925 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' PRO . . . . . 0.411 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 57.3 Cg_endo -71.04 -10.86 28.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.987 2.458 . . . . 8.9900000000000002 112.862 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.19 -5.77 58.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.866 0.365 . . . . 7.96 110.835 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -104.02 115.84 31.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.871 -0.418 . . . . 9.4700000000000006 109.871 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.53 158.99 38.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.267 -0.424 . . . . 7.6299999999999999 110.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -86.85 126.79 40.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.77 -0.65 . . . . 8.4100000000000001 109.982 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 p -72.51 132.5 33.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 6.75 111.928 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.2 -177.87 4.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.397 -0.819 . . . . 7.4699999999999998 109.607 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.44 ' HA ' ' NH2' ' B' ' 89' ' ' ARG . 4.8 mm-40 -76.98 159.65 29.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 6.75 110.593 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.01 151.43 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.316 -0.402 . . . . 5.8700000000000001 111.198 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.48 -19.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.498 0.666 . . . . 7.2199999999999998 109.449 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -92.97 135.45 34.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.471 -0.786 . . . . 5.5199999999999996 109.422 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.3 19.93 6.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 5.5599999999999996 111.175 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -73.16 127.12 31.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.584 -0.524 . . . . 4.4199999999999999 109.584 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -76.43 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.774 0.657 . . . . 3.5899999999999999 112.774 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -130.88 36.74 3.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.546 -0.462 . . . . 3.0499999999999998 111.589 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 1.1 t -142.32 142.52 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 4.5300000000000002 111.093 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 23.3 m -124.54 158.88 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 4.9800000000000004 109.246 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.2 136.72 54.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.881 0.372 . . . . 6.0300000000000002 111.107 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LEU . . . . . . . . . . . . . 6.4 mt -139.65 158.95 43.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 6.9299999999999997 109.771 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.01 145.72 42.23 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.361 -0.382 . . . . 8.0500000000000007 110.509 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLN . . . . . 0.548 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 8.6 tp-100 -54.22 -50.39 84.93 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 119.541 -0.266 . . . . 7.9100000000000001 111.474 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' B' ' 43' ' ' GLN . 10.4 Cg_endo -54.07 -40.88 79.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.327 2.018 . . . . 8.7599999999999998 111.921 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.411 ' HE3' ' O ' ' B' ' 23' ' ' PRO . 0.3 OUTLIER -69.11 -37.92 78.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.505 . . . . 8.6600000000000001 110.514 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' MET . . . . . 0.601 ' SD ' ' OG ' ' B' ' 73' ' ' SER . 85.4 mtp -63.9 -31.36 72.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.05 0.452 . . . . 7.1200000000000001 110.084 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.39 -36.77 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 7.9199999999999999 109.808 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.09 -35.87 80.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.591 -0.732 . . . . 8.9600000000000009 111.161 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 mt -91.83 -6.12 52.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.121 -0.49 . . . . 7.2699999999999996 111.401 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 60.59 64.35 1.2 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.271 0.558 . . . . 8.0899999999999999 110.644 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.3 mt -108.35 148.71 29.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.708 -0.678 . . . . 6.3399999999999999 110.391 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -93.16 -146.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 6.5800000000000001 111.442 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ARG . . . . . . . . . . . . . 7.5 ttt180 -82.48 -87.33 0.1 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.369 -0.378 . . . . 7.4000000000000004 110.283 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' GLY . . . . . . . . . . . . . . . -95.51 54.53 1.73 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.005 -0.838 . . . . 4.4199999999999999 111.005 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -78.14 152.13 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.276 0.56 . . . . 5.0499999999999998 111.695 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.13 107.24 19.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.322 -0.854 . . . . 3.9100000000000001 110.143 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.41 143.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.217 0.532 . . . . 4.9500000000000002 111.747 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 tp -100.23 124.56 45.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 5.1299999999999999 109.411 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.34 114.23 27.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 5.1399999999999997 110.476 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.418 ' HG2' ' HG2' ' B' ' 66' ' ' GLU . 73.6 mttt -94.65 121.76 36.54 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.766 -0.457 . . . . 6.3399999999999999 109.766 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.82 -138.13 8.55 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.684 -0.77 . . . . 6.0700000000000003 112.536 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . 0.413 ' HZ2' ' CG ' ' B' ' 98' ' ' ASP . 41.4 mttp -99.17 170.14 8.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.851 0.358 . . . . 7.2400000000000002 111.464 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 59.12 27.52 16.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.469 -0.787 . . . . 6.1699999999999999 111.242 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 60.87 26.73 16.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.122 -0.944 . . . . 7.8200000000000003 112.698 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ARG . . . . . 0.602 ' HD3' ' O ' ' B' ' 91' ' ' ASN . 60.3 ttt-85 -106.33 136.24 46.41 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.403 -0.519 . . . . 5.3399999999999999 110.773 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' GLU . . . . . 0.418 ' HG2' ' HG2' ' B' ' 60' ' ' LYS . 1.3 mp0 -124.62 149.67 46.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 5.29 110.776 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.83 155.56 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.125 -0.489 . . . . 4.21 109.888 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' VAL . . . . . 0.402 ' HB ' ' HB2' ' B' ' 145' ' ' PRO . 2.8 t -117.48 132.94 65.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.411 -0.218 . . . . 3.6400000000000001 110.411 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' CYS . . . . . . . . . . . . . 91.8 m -148.85 176.14 10.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.847 0.356 . . . . 3.73 111.129 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 42.7 mm -99.26 136.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.276 -0.638 . . . . 4.0 109.276 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.98 131.68 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.397 0.618 . . . . 5.4800000000000004 112.272 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 mt -120.45 144.3 48.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 5.7400000000000002 110.0 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' SER . . . . . 1.136 ' HG ' ' CB ' ' B' ' 73' ' ' SER . 67.5 m -79.31 128.67 33.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.535 -0.302 . . . . 6.75 110.796 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -135.61 130.73 34.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.322 -0.399 . . . . 7.46 110.454 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 8.5700000000000003 110.412 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -2.13 57.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.057 -0.52 . . . . 8.4800000000000004 110.488 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' CYS . . . . . 0.414 ' SG ' ' HG3' ' B' ' 83' ' ' ARG . 3.7 t -89.54 139.52 30.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.5 . . . . 8.2400000000000002 110.323 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -176.18 2.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.987 -0.551 . . . . 8.9299999999999997 110.844 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.19 -20.74 20.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.952 0.406 . . . . 9.1600000000000001 111.186 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.98 7.43 13.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 9.6899999999999995 111.268 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -123.83 152.96 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 8.4399999999999995 111.413 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 tt -128.34 134.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.329 -0.85 . . . . 6.8099999999999996 109.172 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ARG . . . . . 0.414 ' HG3' ' SG ' ' B' ' 77' ' ' CYS . 43.4 mtt-85 -95.54 134.77 38.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.77 0.319 . . . . 7.7699999999999996 111.493 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' MET . . . . . . . . . . . . . 20.3 ptp -152.68 163.07 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.823 -0.436 . . . . 5.5 109.823 179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.23 170.98 15.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.154 0.502 . . . . 4.6500000000000004 111.581 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -66.33 -39.44 89.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.469 -0.787 . . . . 4.7599999999999998 112.418 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.3 -57.37 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 3.5499999999999998 111.888 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.99 -40.06 79.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 4.0999999999999996 110.81 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.44 ' NH2' ' HA ' ' B' ' 30' ' ' GLU . 35.7 ttm180 -59.23 -52.45 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 5.5 110.891 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.08 -36.89 85.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 4.0599999999999996 111.439 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' ASN . . . . . 0.602 ' O ' ' HD3' ' B' ' 65' ' ' ARG . 2.7 m-20 -74.77 -17.22 60.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 3.8700000000000001 111.038 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -90.3 -2.48 58.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 4.9800000000000004 109.056 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 62.53 29.59 17.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.632 -1.167 . . . . 5.3399999999999999 110.914 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.54 156.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 5.9000000000000004 110.262 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -122.14 -178.81 3.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.466 -0.333 . . . . 6.2999999999999998 110.242 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.5 124.01 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 7.0599999999999996 110.671 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 5.43 59.63 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 7.6900000000000004 112.402 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' ASP . . . . . 0.413 ' CG ' ' HZ2' ' B' ' 62' ' ' LYS . 6.9 t0 -89.58 163.94 14.98 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.945 -0.391 . . . . 7.2599999999999998 109.945 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.89 131.98 62.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.183 0.516 . . . . 8.3100000000000005 111.508 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.09 167.62 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 6.7999999999999998 110.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -116.52 127.36 54.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.467 -0.333 . . . . 6.9000000000000004 110.646 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.64 133.58 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.469 . . . . 6.46 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.99 124.38 5.43 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 6.2300000000000004 110.429 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.78 135.27 55.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.422 2.081 . . . . 6.0099999999999998 111.107 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' CYS . . . . . . . . . . . . . 57.7 m -74.32 111.84 14.52 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.564 -0.289 . . . . 5.1799999999999997 111.582 -178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -74.08 -32.54 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.576 2.184 . . . . 4.7699999999999996 111.646 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.5 117.03 16.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.666 -0.697 . . . . 4.75 110.264 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 163.4 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.828 -0.804 . . . . 3.9700000000000002 108.828 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . 0.48 ' HA ' ' CA ' ' A' ' 14' ' ' GLY . 7.9 ptmt -144.1 156.59 44.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.435 -0.506 . . . . 5.6100000000000003 111.405 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' TYR . . . . . 0.954 ' HH ' HE21 ' A' ' 10' ' ' GLN . 3.8 m-30 -79.81 143.28 34.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.453 -0.794 . . . . 3.5299999999999998 110.423 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' GLY . . . . . 0.403 ' C ' ' H ' ' B' ' 113' ' ' ARG . . . -75.38 102.01 1.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.648 -0.787 . . . . 2.7400000000000002 111.452 179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -80.84 16.05 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 5.8499999999999996 110.706 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ARG . . . . . 0.403 ' H ' ' C ' ' B' ' 111' ' ' GLY . 14.0 ttm180 -170.73 128.07 0.77 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.233 -1.025 . . . . 7.1399999999999997 108.233 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.2 112.1 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.893 0.377 . . . . 2.9500000000000002 110.29 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' HIS . . . . . 0.422 ' HB2' ' HG3' ' B' ' 167' ' ' GLU . 5.9 m170 -112.44 102.64 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 4.9900000000000002 110.462 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 7.9 m -120.25 149.4 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.116 -0.493 . . . . 2.7599999999999998 110.021 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -138.15 141.31 31.64 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.597 0.237 . . . . 3.6600000000000001 111.034 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.93 153.52 25.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.422 2.082 . . . . 3.0299999999999998 111.508 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.9 146.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.169 -0.308 . . . . 2.46 110.169 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.09 -37.47 71.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.738 0.644 . . . . 3.1400000000000001 112.738 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' ASP . . . . . 0.418 ' HA ' ' OE2' ' B' ' 124' ' ' GLU . 2.0 p-10 -77.77 -17.77 57.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.091 0.404 . . . . 2.71 112.091 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 p -91.89 -3.61 55.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.714 -0.394 . . . . 3.04 111.667 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.13 14.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.004 0.431 . . . . 3.9399999999999999 111.485 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' GLU . . . . . 0.418 ' OE2' ' HA ' ' B' ' 121' ' ' ASP . 74.2 mt-10 -73.36 118.08 15.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 4.1600000000000001 110.829 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.14 -12.52 62.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.71 -0.757 . . . . 5.2400000000000002 113.41 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.0 pt -112.97 161.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.163 0.482 . . . . 5.1299999999999999 111.132 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 15.2 t -162.29 154.98 19.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.014 -0.539 . . . . 6.1100000000000003 109.917 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.68 -134.49 9.05 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.472 -0.87 . . . . 5.6799999999999997 112.633 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -116.29 119.22 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.82 0.343 . . . . 5.4100000000000001 110.731 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.67 -9.37 17.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 4.8099999999999996 110.041 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' PHE . . . . . 0.476 ' HA ' ' HB2' ' B' ' 135' ' ' LEU . 56.7 t80 -64.77 -52.98 54.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 5.6500000000000004 111.44 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -77.5 -7.71 56.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.249 -0.432 . . . . 5.3300000000000001 112.099 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.76 -34.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.867 0.692 . . . . 5.2599999999999998 112.867 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.35 -49.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.062 0.764 . . . . 4.4400000000000004 113.062 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' LEU . . . . . 0.476 ' HB2' ' HA ' ' B' ' 131' ' ' PHE . 1.9 mm? -79.28 48.57 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 3.0499999999999998 111.853 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' LYS . . . . . 0.401 ' CB ' ' HD3' ' B' ' 137' ' ' PRO . 13.5 tttt -157.08 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.052 -0.522 . . . . 4.9500000000000002 111.002 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' B' ' 136' ' ' LYS . 24.0 Cg_exo -65.09 -19.5 63.29 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.171 1.914 . . . . 4.1200000000000001 112.271 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.13 -5.6 57.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.428 . . . . 3.21 110.706 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -114.36 -42.01 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 2.3100000000000001 110.42 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' B' ' 141' ' ' GLU . 29.0 tp -62.07 123.3 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.696 -0.684 . . . . 4.4000000000000004 110.576 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' GLU . . . . . 0.556 ' HG2' ' O ' ' B' ' 140' ' ' LEU . 5.2 pt-20 62.06 9.92 3.38 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.919 0.888 . . . . 4.0599999999999996 112.691 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.9 6.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.718 -0.219 . . . . 2.7599999999999998 111.198 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 57.72 60.48 2.78 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.557 0.536 . . . . 2.9100000000000001 111.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -120.15 146.66 42.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 3.2799999999999998 110.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' PRO . . . . . 0.402 ' HB2' ' HB ' ' B' ' 68' ' ' VAL . 98.1 Cg_endo -82.45 136.42 8.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.574 2.183 . . . . 2.4900000000000002 111.925 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.8 pt -138.61 150.67 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.904 0.383 . . . . 2.1699999999999999 111.276 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -119.37 154.58 33.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.094 -0.503 . . . . 4.5199999999999996 109.66 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -61.03 122.44 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 4.1900000000000004 111.013 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.86 58.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.941 -0.647 . . . . 2.7599999999999998 113.139 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' ASP . . . . . 0.486 ' HA ' ' ND2' ' B' ' 91' ' ' ASN . 65.2 m-20 -82.1 150.56 27.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.138 0.469 . . . . 2.52 110.425 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -119.64 129.68 75.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 2.02 109.879 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -120.9 149.63 42.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.875 0.369 . . . . 1.46 110.391 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -108.31 129.39 55.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.001 -0.545 . . . . 2.9700000000000002 110.719 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' VAL . . . . . 0.563 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 88.8 t -98.51 100.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.507 -0.553 . . . . 2.98 109.507 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -90.94 -31.48 16.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.215 -0.448 . . . . 5.1200000000000001 110.286 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -82.93 66.27 3.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.953 -0.641 . . . . 4.7000000000000002 112.055 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' B' ' 158' ' ' MET . . . -172.18 46.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.629 -0.588 . . . . 4.8499999999999996 111.629 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 54.2 mtt 71.62 -64.97 0.37 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.211 0.605 . . . . 7.3799999999999999 111.241 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -114.16 147.25 39.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.39 -0.368 . . . . 5.4400000000000004 110.27 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' B' ' 154' ' ' VAL . . . -83.59 100.37 10.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.28 -0.418 . . . . 3.5499999999999998 110.238 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 t -102.24 141.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 3.2799999999999998 110.928 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.31 128.17 43.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 1.9399999999999999 110.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.31 137.16 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.079 -0.341 . . . . 2.9100000000000001 110.079 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -109.37 132.44 54.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.45 . . . . 2.8999999999999999 111.227 -178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' VAL . . . . . . . . . . . . . 52.2 t -80.35 107.61 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.3900000000000001 109.809 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.82 -51.69 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.133 -0.485 . . . . 3.4900000000000002 110.463 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' GLU . . . . . 0.422 ' HG3' ' HB2' ' B' ' 115' ' ' HIS . 0.0 OUTLIER -172.78 166.88 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 4.29 110.936 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 2.1 p -132.93 -179.02 5.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.703 -0.68 . . . . 3.6899999999999999 109.507 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' ASP . . . . . 0.607 ' HB3' ' HD3' ' B' ' 170' ' ' PRO . 20.2 t70 -64.97 -55.68 25.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.849 -0.34 . . . . 4.2699999999999996 110.593 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' B' ' 169' ' ' ASP . 4.0 Cg_endo -91.64 130.22 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.534 2.156 . . . . 3.9700000000000002 111.414 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 3.1 m -98.66 146.41 31.57 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.263 -0.426 . . . . 4.5499999999999998 110.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' B' ' 147' ' ' ARG . 73.3 Cg_endo -99.1 7.37 28.32 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.895 -1.294 . . . . 4.5199999999999996 113.081 -0.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -152.15 167.48 28.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.527 0.204 . . . . 4.71 111.229 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' CYS . . . . . 0.432 ' HB3' ' HG2' ' B' ' 170' ' ' PRO . 29.2 p -172.68 179.43 2.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 2.75 110.265 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ILE . . . . . . . . . . . . . 75.0 mt -102.07 136.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.948 -0.39 . . . . 2.4700000000000002 109.948 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.19 114.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 2.0699999999999998 110.979 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.52 111.01 57.37 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.675 -0.693 . . . . 2.3900000000000001 109.508 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -68.64 -12.31 34.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.631 2.22 . . . . 3.0600000000000001 112.401 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.52 -13.01 47.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.756 -0.656 . . . . 3.27 110.503 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 33.3 m -90.89 143.88 26.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 3.3399999999999999 110.387 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' VAL . . . . . . . . . . . . . 19.7 t -80.09 112.01 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.714 0.292 . . . . 4.0599999999999996 110.55 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 1.8 mt -69.04 141.97 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.48 -0.563 . . . . 3.4399999999999999 109.48 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -122.95 121.53 36.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.154 0.502 . . . . 5.2999999999999998 111.086 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' CYS . . . . . . . . . . . . . 5.6 t -126.32 106.59 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.721 -0.672 . . . . 4.1100000000000003 110.066 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.09 153.02 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.046 -0.525 . . . . 4.8200000000000003 110.146 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.31 53.46 4.77 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 4.8600000000000003 112.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.05 104.27 4.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.154 -0.313 . . . . 5.1399999999999997 110.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.5 149.53 90.83 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.748 2.299 . . . . 4.0899999999999999 111.91 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' ILE . . . . . . . . . . . . . 11.6 pt -108.5 154.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.745 0.307 . . . . 3.3300000000000001 111.152 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -84.32 154.47 22.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 4.3799999999999999 110.156 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' ARG . . . . . 0.6 ' NH1' ' HA ' ' B' ' 197' ' ' SER . 27.4 ttm-85 -88.43 144.99 26.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 2.3399999999999999 110.727 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -83.78 166.11 18.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.436 -0.347 . . . . 3.4100000000000001 110.282 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.92 -36.55 67.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.037 0.384 . . . . 3.4300000000000002 112.037 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.88 -5.89 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.873 0.368 . . . . 3.8300000000000001 111.418 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -104.31 108.99 20.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 2.5800000000000001 110.189 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.24 168.51 19.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.195 -0.457 . . . . 3.4199999999999999 110.876 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' SER . . . . . 0.6 ' HA ' ' NH1' ' B' ' 191' ' ' ARG . 43.3 t -96.34 138.93 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.028 -0.533 . . . . 2.46 110.046 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.77 0.35 13.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.115 0.483 . . . . 2.9300000000000002 110.418 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -8.25 57.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.98 -0.748 . . . . 3.48 108.98 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -65.33 152.73 43.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.379 -0.828 . . . . 3.6099999999999999 110.352 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.4 t -82.97 106.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.078 0.466 . . . . 4.9800000000000004 110.501 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -103.5 -157.88 24.77 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.873 -0.68 . . . . 5.0199999999999996 111.529 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -77.06 -24.52 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.473 . . . . 6.2000000000000002 110.137 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.13 -7.99 57.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.744 -0.662 . . . . 5.4800000000000004 110.956 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.5 0.09 56.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 5.7300000000000004 110.265 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.67 121.77 59.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.808 -0.633 . . . . 6.8200000000000003 109.692 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.5 143.72 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.79 -0.719 . . . . 7.5199999999999996 112.349 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.06 -55.46 4.92 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.224 -0.513 . . . . 8.4000000000000004 112.558 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' CYS . . . . . . . . . . . . . 5.9 m -69.16 97.01 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 8.2599999999999998 110.789 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -109.03 -55.68 2.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.537 . . . . 9.1699999999999999 110.34 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.48 -2.67 43.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 9.7799999999999994 110.303 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -90.85 2.95 55.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 9.6300000000000008 109.571 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.321 -0.854 . . . . 7.9800000000000004 109.472 179.526 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.63 0.253 . . . . 13.35 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.37 130.4 56.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 11.23 111.02 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -122.16 119.04 30.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.23 -0.441 . . . . 9.85 110.442 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.99 86.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.306 0.574 . . . . 7.69 110.326 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -115.2 29.6 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.904 -0.589 . . . . 7.53 110.649 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -56.66 138.1 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.792 -0.64 . . . . 4.19 111.377 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 147.76 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.237 -0.438 . . . . 6.16 110.501 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 6.8 m -111.97 137.74 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 5.59 110.624 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' ' OH ' ' B' ' 110' ' ' TYR . 22.3 mt-30 -85.55 97.7 10.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.888 0.375 . . . . 6.9 110.669 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -98.98 160.25 28.18 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.408 -0.59 . . . . 9.11 109.408 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.68 -26.3 55.21 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.659 2.239 . . . . 11.74 112.386 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.04 -41.65 14.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.177 -0.465 . . . . 12.56 110.725 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' B' ' 109' ' ' LYS . . . 178.53 177.8 47.44 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.741 -0.743 . . . . 10.11 112.749 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 3.9 t -104.4 98.71 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.517 -0.549 . . . . 8.26 109.517 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -114.91 166.94 11.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.243 0.544 . . . . 10.6 112.215 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -78.22 111.32 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 8.69 110.527 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.43 154.87 5.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.856 -0.611 . . . . 6.48 110.407 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.4 92.89 2.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.99 0.424 . . . . 8.37 110.138 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.67 158.73 26.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 7.23 110.793 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.99 -176.46 3.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 8.41 110.174 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.12 -38.3 85.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 12.35 110.32 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -138.95 134.83 33.67 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.027 -0.533 . . . . 11.41 110.798 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -168.87 150.71 4.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 6.92 109.872 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -97.45 177.51 5.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.8 0.333 . . . . 7.68 111.566 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.36 85.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.997 -0.547 . . . . 5.3 110.819 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.72 78.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 5.48 110.789 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.1 m -66.95 -41.18 87.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.002 -0.545 . . . . 5.73 110.383 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.74 -41.12 68.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.988 -0.551 . . . . 3.36 110.588 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 mt -60.19 -33.76 72.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 4.44 110.282 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.64 -33.42 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 6.92 110.37 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 28' ' ' THR . 98.4 mttt -66.84 -52.5 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 5.43 110.833 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.84 -22.29 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 5.99 110.901 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . . . -70.16 -20.95 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 6.86 110.927 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -108.17 -43.5 4.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.078 -0.51 . . . . 8.36 110.832 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -65.74 -47.8 74.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 8.83 111.673 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.24 -18.92 15.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.161 0.505 . . . . 9.07 110.467 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.86 25.44 58.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.812 -0.709 . . . . 8.45 111.972 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.5 m-85 -82.36 170.46 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.895 -0.409 . . . . 8.81 109.895 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -106.05 147.57 28.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.919 -0.4 . . . . 8.05 109.919 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -62.87 -26.57 68.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 5.82 111.243 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -95.51 12.02 30.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 8.28 110.97 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.02 -47.83 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.888 -0.672 . . . . 8.17 112.232 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -60.75 123.89 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 6.83 110.601 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -107.83 136.79 46.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.009 -0.542 . . . . 8.42 110.364 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.99 122.96 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 6.51 110.776 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -133.57 137.08 45.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.717 -0.475 . . . . 10.69 109.717 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 69' ' ' ILE . 9.4 pt -120.4 32.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.444 -0.343 . . . . 7.3 111.887 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.09 169.03 23.96 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.363 -0.236 . . . . 9.68 110.363 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 24.6 ptt85 -81.57 -151.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 10.13 110.21 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 14.7 m120 68.08 51.95 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 12.5 109.774 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' N ' ' HB2' ' B' ' 141' ' ' GLU . 53.2 tttt -53.51 -39.73 64.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.081 -0.963 . . . . 11.81 112.258 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.75 -25.52 62.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 14.74 110.774 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . -80.14 -8.53 87.54 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.855 -0.611 . . . . 13.28 111.928 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HA ' ' OG ' ' A' ' 59' ' ' SER . 36.1 mt-10 -72.32 -19.77 61.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.019 0.437 . . . . 12.08 110.352 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 mt -75.25 94.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.76 -0.655 . . . . 14.54 111.399 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m 70.73 -46.1 0.62 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.204 0.816 . . . . 15.46 113.204 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 54' ' ' GLY . . . -59.34 -23.41 62.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.676 0.621 . . . . 14.71 112.676 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 55' ' ' GLU . 64.9 m -93.4 91.45 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.916 0.389 . . . . 12.9 110.649 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.91 18.4 17.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 13.96 110.475 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.9 160.53 30.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 11.82 110.848 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.39 127.76 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.553 -0.294 . . . . 13.51 110.607 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.19 15.09 2.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 8.94 111.063 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.5 mt -84.55 -151.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 10.72 110.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -66.8 -8.55 29.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.571 0.224 . . . . 13.82 111.486 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.75 -50.7 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 12.84 110.811 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 67' ' ' LEU . 16.7 mt -80.25 -24.17 40.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 10.78 111.574 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mttm 63.93 91.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.427 0.454 . . . . 13.72 111.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG12 HD13 ' A' ' 48' ' ' ILE . 46.9 mt -86.27 129.36 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.055 -0.52 . . . . 8.67 109.966 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -81.02 166.37 20.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 10.36 110.664 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -75.91 77.16 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.143 0.497 . . . . 6.84 110.408 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.93 30.86 0.85 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.709 -0.678 . . . . 5.23 112.262 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 134.94 52.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.663 -0.495 . . . . 5.53 109.663 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mt -76.78 133.81 39.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 5.44 111.042 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -90.49 111.77 23.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 4.73 109.998 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -83.01 101.23 10.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.06 -0.518 . . . . 9.33 110.002 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 25.4 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.584 -0.722 . . . . 8.42 110.367 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.316 -0.253 . . . . 10.49 110.316 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 70.3 99.16 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.753 -0.658 . . . . 9.27 110.925 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 23' ' ' PRO . . . . . 0.431 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 57.3 Cg_endo -71.04 -10.86 28.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.987 2.458 . . . . 8.68 112.862 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.19 -5.77 58.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.866 0.365 . . . . 7.81 110.835 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -104.02 115.84 31.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.871 -0.418 . . . . 9.2 109.871 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.53 158.99 38.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.267 -0.424 . . . . 7.4 110.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -86.85 126.79 40.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.77 -0.65 . . . . 8.18 109.982 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.407 HG23 ' HG2' ' B' ' 84' ' ' MET . 2.7 p -72.51 132.5 33.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 6.71 111.928 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.2 -177.87 4.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.397 -0.819 . . . . 7.47 109.607 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.448 ' HA ' ' NH2' ' B' ' 89' ' ' ARG . 4.8 mm-40 -76.98 159.65 29.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 6.41 110.593 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.01 151.43 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.316 -0.402 . . . . 5.82 111.198 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.48 -19.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.498 0.666 . . . . 6.97 109.449 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -92.97 135.45 34.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.471 -0.786 . . . . 5.52 109.422 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.3 19.93 6.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 5.56 111.175 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' B' ' 38' ' ' VAL . 6.6 t70 -73.16 127.12 31.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.584 -0.524 . . . . 4.42 109.584 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -76.43 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.774 0.657 . . . . 3.59 112.774 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -130.88 36.74 3.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.546 -0.462 . . . . 3.05 111.589 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 35' ' ' ASP . 1.1 t -142.32 142.52 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 4.26 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 23.3 m -124.54 158.88 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 4.95 109.246 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.2 136.72 54.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.881 0.372 . . . . 6.03 111.107 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 41' ' ' LEU . 6.4 mt -139.65 158.95 43.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 6.74 109.771 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.01 145.72 42.23 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.361 -0.382 . . . . 7.77 110.509 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLN . . . . . 0.55 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 61.6 tp60 -54.22 -50.39 84.93 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 119.541 -0.266 . . . . 7.61 111.474 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' B' ' 43' ' ' GLN . 10.4 Cg_endo -54.07 -40.88 79.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.327 2.018 . . . . 8.54 111.921 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' B' ' 23' ' ' PRO . 0.3 OUTLIER -69.11 -37.92 78.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.505 . . . . 8.41 110.514 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' MET . . . . . 0.553 ' SD ' ' OG ' ' B' ' 73' ' ' SER . 85.4 mtp -63.9 -31.36 72.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.05 0.452 . . . . 7.04 110.084 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.39 -36.77 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 7.84 109.808 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.09 -35.87 80.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.591 -0.732 . . . . 8.96 111.161 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 mt -91.83 -6.12 52.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.121 -0.49 . . . . 7.24 111.401 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 60.59 64.35 1.2 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.271 0.558 . . . . 7.68 110.644 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.3 mt -108.35 148.71 29.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.708 -0.678 . . . . 6.03 110.391 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -93.16 -146.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 6.08 111.442 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 53' ' ' ARG . 7.5 ttt180 -82.48 -87.33 0.1 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.369 -0.378 . . . . 6.89 110.283 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' B' ' 53' ' ' ARG . . . -95.51 54.53 1.73 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.005 -0.838 . . . . 4.09 111.005 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -78.14 152.13 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.276 0.56 . . . . 5.05 111.695 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.13 107.24 19.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.322 -0.854 . . . . 3.91 110.143 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.41 143.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.217 0.532 . . . . 4.72 111.747 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 tp -100.23 124.56 45.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 5.04 109.411 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.34 114.23 27.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 4.97 110.476 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' B' ' 66' ' ' GLU . 73.6 mttt -94.65 121.76 36.54 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.766 -0.457 . . . . 6.1 109.766 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.82 -138.13 8.55 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.684 -0.77 . . . . 6.07 112.536 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -99.17 170.14 8.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.851 0.358 . . . . 7.01 111.464 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 59.12 27.52 16.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.469 -0.787 . . . . 5.91 111.242 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 60.87 26.73 16.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.122 -0.944 . . . . 7.5 112.698 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' B' ' 91' ' ' ASN . 60.3 ttt-85 -106.33 136.24 46.41 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.403 -0.519 . . . . 5.23 110.773 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' B' ' 60' ' ' LYS . 1.3 mp0 -124.62 149.67 46.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 5.29 110.776 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.83 155.56 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.125 -0.489 . . . . 3.99 109.888 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 145' ' ' PRO . 2.8 t -117.48 132.94 65.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.411 -0.218 . . . . 3.32 110.411 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' CYS . . . . . . . . . . . . . 91.8 m -148.85 176.14 10.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.847 0.356 . . . . 3.54 111.129 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 42.7 mm -99.26 136.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.276 -0.638 . . . . 4.0 109.276 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.98 131.68 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.397 0.618 . . . . 5.23 112.272 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 mt -120.45 144.3 48.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 5.74 110.0 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' SER . . . . . 1.058 ' CB ' ' OG ' ' B' ' 73' ' ' SER . 67.5 m -79.31 128.67 33.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.535 -0.302 . . . . 6.45 110.796 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -135.61 130.73 34.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.322 -0.399 . . . . 7.46 110.454 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 8.57 110.412 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -2.13 57.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.057 -0.52 . . . . 8.16 110.488 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 77' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' B' ' 83' ' ' ARG . 3.7 t -89.54 139.52 30.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.5 . . . . 8.24 110.323 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -176.18 2.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.987 -0.551 . . . . 8.59 110.844 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.19 -20.74 20.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.952 0.406 . . . . 9.15 111.186 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.98 7.43 13.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 9.69 111.268 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -123.83 152.96 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 8.23 111.413 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 tt -128.34 134.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.329 -0.85 . . . . 6.79 109.172 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ARG . . . . . 0.43 ' HG3' ' SG ' ' B' ' 77' ' ' CYS . 43.4 mtt-85 -95.54 134.77 38.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.77 0.319 . . . . 7.6 111.493 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 84' ' ' MET . . . . . 0.407 ' HG2' HG23 ' B' ' 28' ' ' VAL . 20.3 ptp -152.68 163.07 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.823 -0.436 . . . . 5.33 109.823 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.23 170.98 15.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.154 0.502 . . . . 4.5 111.581 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -66.33 -39.44 89.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.469 -0.787 . . . . 4.56 112.418 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.3 -57.37 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 3.5 111.888 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.99 -40.06 79.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 3.92 110.81 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.448 ' NH2' ' HA ' ' B' ' 30' ' ' GLU . 35.7 ttm180 -59.23 -52.45 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 5.38 110.891 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.08 -36.89 85.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 3.95 111.439 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 91' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' B' ' 65' ' ' ARG . 2.7 m-20 -74.77 -17.22 60.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 3.87 111.038 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -90.3 -2.48 58.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 4.98 109.056 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 62.53 29.59 17.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.632 -1.167 . . . . 5.34 110.914 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.54 156.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 5.68 110.262 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -122.14 -178.81 3.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.466 -0.333 . . . . 6.23 110.242 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.5 124.01 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 7.06 110.671 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 5.43 59.63 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 7.69 112.402 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.58 163.94 14.98 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.945 -0.391 . . . . 7.07 109.945 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.89 131.98 62.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.183 0.516 . . . . 7.99 111.508 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.09 167.62 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 6.77 110.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -116.52 127.36 54.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.467 -0.333 . . . . 6.9 110.646 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.64 133.58 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.469 . . . . 6.26 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.99 124.38 5.43 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 6.23 110.429 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.78 135.27 55.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.422 2.081 . . . . 5.8 111.107 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 57.7 m -74.32 111.84 14.52 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.564 -0.289 . . . . 4.81 111.582 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 105' ' ' CYS . 3.7 Cg_exo -74.08 -32.54 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.576 2.184 . . . . 4.57 111.646 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.5 117.03 16.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.666 -0.697 . . . . 4.51 110.264 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 163.4 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.828 -0.804 . . . . 3.63 108.828 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LYS . . . . . 0.494 ' HA ' ' CA ' ' A' ' 14' ' ' GLY . 7.9 ptmt -144.1 156.59 44.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.435 -0.506 . . . . 5.34 111.405 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 10' ' ' GLN . 3.8 m-30 -79.81 143.28 34.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.453 -0.794 . . . . 3.24 110.423 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.38 102.01 1.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.648 -0.787 . . . . 2.56 111.452 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -80.84 16.05 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 5.53 110.706 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' B' ' 169' ' ' ASP . 14.0 ttm180 -170.73 128.07 0.77 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.233 -1.025 . . . . 6.49 108.233 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.2 112.1 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.893 0.377 . . . . 2.9 110.29 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' HIS . . . . . 0.444 ' HB2' ' HG3' ' B' ' 167' ' ' GLU . 5.9 m170 -112.44 102.64 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 4.52 110.462 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' B' ' 165' ' ' VAL . 7.9 m -120.25 149.4 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.116 -0.493 . . . . 2.76 110.021 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -138.15 141.31 31.64 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.597 0.237 . . . . 3.35 111.034 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.93 153.52 25.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.422 2.082 . . . . 2.85 111.508 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.9 146.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.169 -0.308 . . . . 2.46 110.169 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.09 -37.47 71.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.738 0.644 . . . . 2.98 112.738 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' ASP . . . . . 0.42 ' HA ' ' OE2' ' B' ' 124' ' ' GLU . 2.0 p-10 -77.77 -17.77 57.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.091 0.404 . . . . 2.71 112.091 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 p -91.89 -3.61 55.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.714 -0.394 . . . . 3.04 111.667 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.13 14.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.004 0.431 . . . . 3.94 111.485 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' B' ' 121' ' ' ASP . 74.2 mt-10 -73.36 118.08 15.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 4.16 110.829 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.14 -12.52 62.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.71 -0.757 . . . . 5.24 113.41 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.0 pt -112.97 161.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.163 0.482 . . . . 4.89 111.132 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 15.2 t -162.29 154.98 19.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.014 -0.539 . . . . 5.89 109.917 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.68 -134.49 9.05 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.472 -0.87 . . . . 5.44 112.633 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -116.29 119.22 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.82 0.343 . . . . 5.15 110.731 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.67 -9.37 17.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 4.59 110.041 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 135' ' ' LEU . 56.7 t80 -64.77 -52.98 54.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 5.12 111.44 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -77.5 -7.71 56.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.249 -0.432 . . . . 5.33 112.099 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.76 -34.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.867 0.692 . . . . 4.94 112.867 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.35 -49.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.062 0.764 . . . . 4.31 113.062 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' ' 131' ' ' PHE . 1.9 mm? -79.28 48.57 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 2.8 111.853 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 136' ' ' LYS . . . . . 0.406 ' CB ' ' HD3' ' B' ' 137' ' ' PRO . 13.5 tttt -157.08 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.052 -0.522 . . . . 4.72 111.002 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' B' ' 136' ' ' LYS . 24.0 Cg_exo -65.09 -19.5 63.29 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.171 1.914 . . . . 3.84 112.271 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.13 -5.6 57.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.428 . . . . 2.93 110.706 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -114.36 -42.01 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 2.22 110.42 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 140' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' B' ' 141' ' ' GLU . 29.0 tp -62.07 123.3 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.696 -0.684 . . . . 4.03 110.576 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 141' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 140' ' ' LEU . 5.2 pt-20 62.06 9.92 3.38 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.919 0.888 . . . . 4.06 112.691 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.9 6.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.718 -0.219 . . . . 2.43 111.198 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 143' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 57.72 60.48 2.78 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.557 0.536 . . . . 2.73 111.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -120.15 146.66 42.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 3.04 110.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' PRO . . . . . 0.435 ' HB2' ' HB ' ' B' ' 68' ' ' VAL . 98.1 Cg_endo -82.45 136.42 8.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.574 2.183 . . . . 2.28 111.925 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.8 pt -138.61 150.67 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.904 0.383 . . . . 2.17 111.276 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 147' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -119.37 154.58 33.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.094 -0.503 . . . . 4.21 109.66 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -61.03 122.44 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 3.82 111.013 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.86 58.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.941 -0.647 . . . . 2.52 113.139 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' ASP . . . . . 0.496 ' HA ' ' ND2' ' B' ' 91' ' ' ASN . 65.2 m-20 -82.1 150.56 27.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.138 0.469 . . . . 2.52 110.425 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -119.64 129.68 75.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 1.65 109.879 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -120.9 149.63 42.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.875 0.369 . . . . 1.32 110.391 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -108.31 129.39 55.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.001 -0.545 . . . . 2.62 110.719 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 88.8 t -98.51 100.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.507 -0.553 . . . . 2.85 109.507 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -90.94 -31.48 16.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.215 -0.448 . . . . 4.82 110.286 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -82.93 66.27 3.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.953 -0.641 . . . . 4.7 112.055 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' B' ' 158' ' ' MET . . . -172.18 46.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.629 -0.588 . . . . 4.71 111.629 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 158' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 54.2 mtt 71.62 -64.97 0.37 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.211 0.605 . . . . 7.05 111.241 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -114.16 147.25 39.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.39 -0.368 . . . . 5.18 110.27 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 154' ' ' VAL . . . -83.59 100.37 10.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.28 -0.418 . . . . 3.42 110.238 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 t -102.24 141.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 3.01 110.928 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.31 128.17 43.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 1.89 110.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.31 137.16 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.079 -0.341 . . . . 2.57 110.079 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 164' ' ' LYS . . . . . 0.425 ' HB3' HD11 ' B' ' 189' ' ' ILE . 83.4 tttt -109.37 132.44 54.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.45 . . . . 2.59 111.227 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' B' ' 116' ' ' VAL . 52.2 t -80.35 107.61 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.34 109.809 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.82 -51.69 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.133 -0.485 . . . . 3.3 110.463 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' B' ' 115' ' ' HIS . 0.0 OUTLIER -172.78 166.88 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 4.29 110.936 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 2.1 p -132.93 -179.02 5.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.703 -0.68 . . . . 3.69 109.507 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' ASP . . . . . 0.617 ' HB3' ' HD3' ' B' ' 170' ' ' PRO . 20.2 t70 -64.97 -55.68 25.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.849 -0.34 . . . . 4.27 110.593 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 170' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 169' ' ' ASP . 4.0 Cg_endo -91.64 130.22 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.534 2.156 . . . . 3.68 111.414 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 3.1 m -98.66 146.41 31.57 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.263 -0.426 . . . . 4.28 110.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 172' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' B' ' 147' ' ' ARG . 73.3 Cg_endo -99.1 7.37 28.32 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.895 -1.294 . . . . 4.25 113.081 -0.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -152.15 167.48 28.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.527 0.204 . . . . 4.44 111.229 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' CYS . . . . . 0.435 ' HB3' ' HG2' ' B' ' 170' ' ' PRO . 29.2 p -172.68 179.43 2.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.265 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 15' ' ' VAL . 75.0 mt -102.07 136.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.948 -0.39 . . . . 2.17 109.948 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.19 114.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 1.69 110.979 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.52 111.01 57.37 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.675 -0.693 . . . . 2.14 109.508 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' PRO . . . . . 0.417 ' HB3' ' H ' ' B' ' 141' ' ' GLU . 49.4 Cg_endo -68.64 -12.31 34.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.631 2.22 . . . . 2.78 112.401 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.52 -13.01 47.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.756 -0.656 . . . . 3.27 110.503 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 33.3 m -90.89 143.88 26.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 3.08 110.387 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' VAL . . . . . . . . . . . . . 19.7 t -80.09 112.01 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.714 0.292 . . . . 3.77 110.55 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 1.8 mt -69.04 141.97 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.48 -0.563 . . . . 3.44 109.48 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -122.95 121.53 36.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.154 0.502 . . . . 4.91 111.086 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 184' ' ' CYS . . . . . . . . . . . . . 5.6 t -126.32 106.59 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.721 -0.672 . . . . 4.11 110.066 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.09 153.02 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.046 -0.525 . . . . 4.82 110.146 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.31 53.46 4.77 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 4.76 112.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.05 104.27 4.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.154 -0.313 . . . . 5.14 110.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.5 149.53 90.83 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.748 2.299 . . . . 3.89 111.91 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' B' ' 164' ' ' LYS . 11.6 pt -108.5 154.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.745 0.307 . . . . 3.06 111.152 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -84.32 154.47 22.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 4.07 110.156 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' ARG . . . . . 0.611 ' NH1' ' HA ' ' B' ' 197' ' ' SER . 27.4 ttm-85 -88.43 144.99 26.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 2.34 110.727 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -83.78 166.11 18.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.436 -0.347 . . . . 3.41 110.282 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.92 -36.55 67.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.037 0.384 . . . . 3.43 112.037 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.88 -5.89 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.873 0.368 . . . . 3.83 111.418 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -104.31 108.99 20.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 2.52 110.189 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.24 168.51 19.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.195 -0.457 . . . . 3.42 110.876 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' SER . . . . . 0.611 ' HA ' ' NH1' ' B' ' 191' ' ' ARG . 43.3 t -96.34 138.93 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.028 -0.533 . . . . 2.46 110.046 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 198' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.77 0.35 13.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.115 0.483 . . . . 2.93 110.418 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 199' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -8.25 57.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.98 -0.748 . . . . 3.37 108.98 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -65.33 152.73 43.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.379 -0.828 . . . . 3.61 110.352 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.4 t -82.97 106.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.078 0.466 . . . . 4.76 110.501 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -103.5 -157.88 24.77 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.873 -0.68 . . . . 5.02 111.529 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -77.06 -24.52 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.473 . . . . 5.97 110.137 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 204' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.13 -7.99 57.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.744 -0.662 . . . . 5.39 110.956 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.5 0.09 56.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 5.73 110.265 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.67 121.77 59.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.808 -0.633 . . . . 6.63 109.692 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.5 143.72 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.79 -0.719 . . . . 7.52 112.349 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.06 -55.46 4.92 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.224 -0.513 . . . . 8.4 112.558 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' CYS . . . . . . . . . . . . . 5.9 m -69.16 97.01 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 7.96 110.789 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -109.03 -55.68 2.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.537 . . . . 8.91 110.34 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.48 -2.67 43.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 9.47 110.303 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -90.85 2.95 55.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 9.37 109.571 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.321 -0.854 . . . . 7.87 109.472 179.526 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 120.63 0.253 . . . . 13.35 110.439 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -113.37 130.4 56.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.57 -0.286 . . . . 11.23 111.02 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.9 m -122.16 119.04 30.11 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.23 -0.441 . . . . 9.85 110.442 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.5 mm -82.99 86.45 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.306 0.574 . . . . 7.69 110.326 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 16.7 pt -115.2 29.6 2.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.904 -0.589 . . . . 7.53 110.649 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.6 tt -56.66 138.1 17.74 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 CA-C-N 115.792 -0.64 . . . . 4.19 111.377 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -122.79 147.76 46.16 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.237 -0.438 . . . . 6.16 110.501 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 15' ' ' VAL . 6.8 m -111.97 137.74 43.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.294 -0.412 . . . . 5.59 110.624 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.603 ' HB3' ' OH ' ' B' ' 110' ' ' TYR . 22.3 mt-30 -85.55 97.7 10.21 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.888 0.375 . . . . 6.9 110.669 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.1 m -98.98 160.25 28.18 Favored Pre-proline 0 C--N 1.318 -0.778 0 N-CA-C 109.408 -0.59 . . . . 9.11 109.408 179.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -55.68 -26.3 55.21 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.659 2.239 . . . . 11.74 112.386 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.04 -41.65 14.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.177 -0.465 . . . . 12.56 110.725 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.494 ' CA ' ' HA ' ' B' ' 109' ' ' LYS . . . 178.53 177.8 47.44 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.741 -0.743 . . . . 10.11 112.749 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 9' ' ' VAL . 3.9 t -104.4 98.71 7.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 109.517 -0.549 . . . . 8.26 109.517 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.7 mmtp -114.91 166.94 11.24 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.243 0.544 . . . . 10.6 112.215 -178.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.3 mtm180 -78.22 111.32 14.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.444 -0.798 . . . . 8.69 110.527 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 10.3 tp -76.43 154.87 5.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.856 -0.611 . . . . 6.48 110.407 -179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -75.4 92.89 2.86 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 120.99 0.424 . . . . 8.37 110.138 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.67 158.73 26.81 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.122 -0.49 . . . . 7.23 110.793 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.99 -176.46 3.04 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.651 -0.704 . . . . 8.41 110.174 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -67.12 -38.3 85.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.897 0.38 . . . . 12.35 110.32 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 25.0 mmm180 -138.95 134.83 33.67 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.027 -0.533 . . . . 11.41 110.798 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -168.87 150.71 4.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.873 -0.603 . . . . 6.92 109.872 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 20.4 p -97.45 177.51 5.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.8 0.333 . . . . 7.68 111.566 -179.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.05 -38.36 85.91 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.997 -0.547 . . . . 5.3 110.819 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.33 -36.72 78.62 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.28 -0.418 . . . . 5.48 110.789 179.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' A' ' 32' ' ' LYS . 2.1 m -66.95 -41.18 87.38 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.002 -0.545 . . . . 5.73 110.383 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -71.74 -41.12 68.84 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 115.988 -0.551 . . . . 3.36 110.588 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 24.1 mt -60.19 -33.76 72.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 4.44 110.282 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -71.64 -33.42 68.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.679 -0.691 . . . . 6.92 110.37 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.454 ' HG3' ' O ' ' A' ' 28' ' ' THR . 98.4 mttt -66.84 -52.5 42.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.042 -0.526 . . . . 5.43 110.833 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.8 m -66.84 -22.29 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.35 -0.386 . . . . 5.99 110.901 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.447 ' HA ' ' O ' ' A' ' 39' ' ' PHE . . . -70.16 -20.95 63.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 6.86 110.927 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -108.17 -43.5 4.37 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.078 -0.51 . . . . 8.36 110.832 179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.1 mm-40 -65.74 -47.8 74.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.898 0.38 . . . . 8.83 111.673 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.24 -18.92 15.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.161 0.505 . . . . 9.07 110.467 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.86 25.44 58.09 Favored Glycine 0 N--CA 1.445 -0.711 0 C-N-CA 120.812 -0.709 . . . . 8.45 111.972 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.447 ' O ' ' HA ' ' A' ' 34' ' ' ALA . 14.5 m-85 -82.36 170.46 15.3 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.895 -0.409 . . . . 8.81 109.895 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -106.05 147.57 28.76 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.919 -0.4 . . . . 8.05 109.919 179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.1 p-10 -62.87 -26.57 68.84 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.217 -0.447 . . . . 5.82 111.243 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -95.51 12.02 30.96 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.234 -0.439 . . . . 8.28 110.97 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -126.02 -47.83 0.2 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.888 -0.672 . . . . 8.17 112.232 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -60.75 123.89 18.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 6.83 110.601 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 m -107.83 136.79 46.96 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.009 -0.542 . . . . 8.42 110.364 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.3 t -94.99 122.96 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.22 -0.446 . . . . 6.51 110.776 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -133.57 137.08 45.33 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.717 -0.475 . . . . 10.69 109.717 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.417 HD13 HG12 ' A' ' 69' ' ' ILE . 9.4 pt -120.4 32.18 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.444 -0.343 . . . . 7.3 111.887 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -153.09 169.03 23.96 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 110.363 -0.236 . . . . 9.68 110.363 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.418 ' O ' ' HB2' ' A' ' 51' ' ' ASN . 24.6 ptt85 -81.57 -151.97 0.09 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 10.13 110.21 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' A' ' 50' ' ' ARG . 14.7 m120 68.08 51.95 0.71 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.265 0.555 . . . . 12.5 109.774 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.438 ' N ' ' HB2' ' B' ' 141' ' ' GLU . 53.2 tttt -53.51 -39.73 64.84 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.081 -0.963 . . . . 11.81 112.258 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -71.75 -25.52 62.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.081 0.467 . . . . 14.74 110.774 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 58' ' ' ALA . . . -80.14 -8.53 87.54 Favored Glycine 0 N--CA 1.448 -0.541 0 CA-C-N 115.855 -0.611 . . . . 13.28 111.928 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.435 ' HA ' ' OG ' ' A' ' 59' ' ' SER . 36.1 mt-10 -72.32 -19.77 61.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.019 0.437 . . . . 12.08 110.352 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 33.9 mt -75.25 94.89 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.76 -0.655 . . . . 14.54 111.399 -179.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 6.7 m 70.73 -46.1 0.62 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.204 0.816 . . . . 15.46 113.204 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 54' ' ' GLY . . . -59.34 -23.41 62.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.676 0.621 . . . . 14.71 112.676 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.435 ' OG ' ' HA ' ' A' ' 55' ' ' GLU . 64.9 m -93.4 91.45 7.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.916 0.389 . . . . 12.9 110.649 179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.91 18.4 17.32 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.014 -0.539 . . . . 13.96 110.475 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m -68.9 160.53 30.54 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.851 -0.613 . . . . 11.82 110.848 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.39 127.76 45.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.553 -0.294 . . . . 13.51 110.607 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.19 15.09 2.05 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.984 0.421 . . . . 8.94 111.063 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 69.5 mt -84.55 -151.79 0.13 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.115 -0.493 . . . . 10.72 110.44 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 30.9 p-80 -66.8 -8.55 29.4 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.571 0.224 . . . . 13.82 111.486 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.3 tp -64.75 -50.7 65.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 12.84 110.811 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 67' ' ' LEU . 16.7 mt -80.25 -24.17 40.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.28 -0.418 . . . . 10.78 111.574 -179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 25.0 mttm 63.93 91.34 0.08 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 123.427 0.454 . . . . 13.72 111.586 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG12 HD13 ' A' ' 48' ' ' ILE . 46.9 mt -86.27 129.36 38.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 116.055 -0.52 . . . . 8.67 109.966 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -81.02 166.37 20.84 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.81 0.338 . . . . 10.36 110.664 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -75.91 77.16 2.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.143 0.497 . . . . 6.84 110.408 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.93 30.86 0.85 Allowed Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 115.709 -0.678 . . . . 5.23 112.262 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.38 134.94 52.42 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.663 -0.495 . . . . 5.53 109.663 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 10.1 mt -76.78 133.81 39.31 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.034 0.445 . . . . 5.44 111.042 -178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 64.0 mt -90.49 111.77 23.16 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.849 -0.614 . . . . 4.73 109.998 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -83.01 101.23 10.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.06 -0.518 . . . . 9.33 110.002 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' A' ' 10' ' ' GLN . 25.4 mt . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.584 -0.722 . . . . 8.42 110.367 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 . . . . . 0 N--CA 1.483 1.177 0 N-CA-C 110.316 -0.253 . . . . 10.49 110.316 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ARG . . . . . . . . . . . . . 19.0 mmm-85 70.3 99.16 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.753 -0.658 . . . . 9.27 110.925 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' PRO . . . . . 0.431 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 57.3 Cg_endo -71.04 -10.86 28.3 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.987 2.458 . . . . 8.68 112.862 -179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ASN . . . . . . . . . . . . . 13.3 p-10 -82.19 -5.77 58.72 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.866 0.365 . . . . 7.81 110.835 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . . . . . . . . . 31.7 mtm180 -104.02 115.84 31.17 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.871 -0.418 . . . . 9.2 109.871 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . . . . . . . . . 1.6 mp -130.53 158.99 38.46 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.267 -0.424 . . . . 7.4 110.946 -179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -86.85 126.79 40.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.77 -0.65 . . . . 8.18 109.982 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.407 HG23 ' HG2' ' B' ' 84' ' ' MET . 2.7 p -72.51 132.5 33.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.326 0.584 . . . . 6.71 111.928 -179.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -132.2 -177.87 4.65 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.397 -0.819 . . . . 7.47 109.607 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.448 ' HA ' ' NH2' ' B' ' 89' ' ' ARG . 4.8 mm-40 -76.98 159.65 29.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.851 0.358 . . . . 6.41 110.593 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -118.01 151.43 37.5 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.316 -0.402 . . . . 5.82 111.198 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 27.4 mm -87.48 -19.9 7.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.498 0.666 . . . . 6.97 109.449 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -92.97 135.45 34.15 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.471 -0.786 . . . . 5.52 109.422 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -92.3 19.93 6.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 5.56 111.175 -179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.41 ' HB3' ' HB ' ' B' ' 38' ' ' VAL . 6.6 t70 -73.16 127.12 31.7 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.584 -0.524 . . . . 4.42 109.584 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -76.43 -12.05 59.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.774 0.657 . . . . 3.59 112.774 -178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' SER . . . . . . . . . . . . . 4.8 m -130.88 36.74 3.85 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.546 -0.462 . . . . 3.05 111.589 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.41 ' HB ' ' HB3' ' B' ' 35' ' ' ASP . 1.1 t -142.32 142.52 27.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.083 0.468 . . . . 4.26 111.093 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' VAL . . . . . . . . . . . . . 23.3 m -124.54 158.88 31.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.635 -0.711 . . . . 4.95 109.246 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.2 136.72 54.07 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.881 0.372 . . . . 6.03 111.107 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LEU . . . . . 0.424 ' HA ' HD23 ' B' ' 41' ' ' LEU . 6.4 mt -139.65 158.95 43.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.719 -0.673 . . . . 6.74 109.771 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.01 145.72 42.23 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.361 -0.382 . . . . 7.77 110.509 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLN . . . . . 0.55 ' N ' ' HD2' ' B' ' 44' ' ' PRO . 8.6 tp-100 -54.22 -50.39 84.93 Favored Pre-proline 0 CA--C 1.541 0.61 0 CA-C-O 119.541 -0.266 . . . . 7.61 111.474 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' B' ' 43' ' ' GLN . 10.4 Cg_endo -54.07 -40.88 79.71 Favored 'Trans proline' 0 C--N 1.359 1.102 0 C-N-CA 122.327 2.018 . . . . 8.54 111.921 178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' B' ' 23' ' ' PRO . 0.3 OUTLIER -69.11 -37.92 78.65 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.088 -0.505 . . . . 8.41 110.514 179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' MET . . . . . 0.553 ' SD ' ' OG ' ' B' ' 73' ' ' SER . 85.4 mtp -63.9 -31.36 72.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.05 0.452 . . . . 7.04 110.084 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -74.39 -36.77 63.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.856 -0.611 . . . . 7.84 109.808 178.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.09 -35.87 80.75 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.591 -0.732 . . . . 8.96 111.161 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 52.3 mt -91.83 -6.12 52.21 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.121 -0.49 . . . . 7.24 111.401 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 60.59 64.35 1.2 Allowed 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.271 0.558 . . . . 7.68 110.644 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LEU . . . . . . . . . . . . . 74.3 mt -108.35 148.71 29.69 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.708 -0.678 . . . . 6.03 110.391 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -93.16 -146.77 0.24 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.934 0.397 . . . . 6.08 111.442 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' B' ' 53' ' ' ARG . 7.5 ttt180 -82.48 -87.33 0.1 Allowed 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.369 -0.378 . . . . 6.89 110.283 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' GLY . . . . . 0.4 ' H ' ' HB3' ' B' ' 53' ' ' ARG . . . -95.51 54.53 1.73 Allowed Glycine 0 N--CA 1.449 -0.455 0 N-CA-C 111.005 -0.838 . . . . 4.09 111.005 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -78.14 152.13 32.93 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.276 0.56 . . . . 5.05 111.695 -178.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.13 107.24 19.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.322 -0.854 . . . . 3.91 110.143 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 m -103.41 143.31 15.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.217 0.532 . . . . 4.72 111.747 -178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' LEU . . . . . . . . . . . . . 31.5 tp -100.23 124.56 45.82 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.336 -0.847 . . . . 5.04 109.411 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' LEU . . . . . . . . . . . . . 14.4 mt -108.34 114.23 27.93 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.162 -0.472 . . . . 4.97 110.476 -179.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' B' ' 66' ' ' GLU . 73.6 mttt -94.65 121.76 36.54 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.766 -0.457 . . . . 6.1 109.766 179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' GLY . . . . . . . . . . . . . . . -107.82 -138.13 8.55 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.684 -0.77 . . . . 6.07 112.536 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -99.17 170.14 8.89 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.851 0.358 . . . . 7.01 111.464 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LYS . . . . . . . . . . . . . 95.7 mttt 59.12 27.52 16.53 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 115.469 -0.787 . . . . 5.91 111.242 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' ARG . . . . . . . . . . . . . 9.0 tpt180 60.87 26.73 16.59 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.122 -0.944 . . . . 7.5 112.698 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ARG . . . . . 0.608 ' HD3' ' O ' ' B' ' 91' ' ' ASN . 60.3 ttt-85 -106.33 136.24 46.41 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.403 -0.519 . . . . 5.23 110.773 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' B' ' 60' ' ' LYS . 1.3 mp0 -124.62 149.67 46.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 5.29 110.776 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -127.83 155.56 43.91 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.125 -0.489 . . . . 3.99 109.888 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' VAL . . . . . 0.435 ' HB ' ' HB2' ' B' ' 145' ' ' PRO . 2.8 t -117.48 132.94 65.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 110.411 -0.218 . . . . 3.32 110.411 -179.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' CYS . . . . . . . . . . . . . 91.8 m -148.85 176.14 10.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.847 0.356 . . . . 3.54 111.129 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 42.7 mm -99.26 136.93 28.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 109.276 -0.638 . . . . 4.0 109.276 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.98 131.68 42.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.397 0.618 . . . . 5.23 112.272 -178.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' LEU . . . . . . . . . . . . . 61.4 mt -120.45 144.3 48.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.812 -0.631 . . . . 5.74 110.0 178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' SER . . . . . 1.058 ' CB ' ' OG ' ' B' ' 73' ' ' SER . 67.5 m -79.31 128.67 33.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.535 -0.302 . . . . 6.45 110.796 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -135.61 130.73 34.87 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.322 -0.399 . . . . 7.46 110.454 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -80.34 -15.07 57.73 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.105 -0.498 . . . . 8.57 110.412 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.36 -2.13 57.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.057 -0.52 . . . . 8.16 110.488 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' CYS . . . . . 0.43 ' SG ' ' HG3' ' B' ' 83' ' ' ARG . 3.7 t -89.54 139.52 30.45 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.101 -0.5 . . . . 8.24 110.323 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.81 -176.18 2.77 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.987 -0.551 . . . . 8.59 110.844 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -92.19 -20.74 20.88 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.952 0.406 . . . . 9.15 111.186 -179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -116.98 7.43 13.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.008 -0.542 . . . . 9.69 111.268 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 62.2 mttm -123.83 152.96 41.71 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.929 0.395 . . . . 8.23 111.413 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ILE . . . . . . . . . . . . . 12.9 tt -128.34 134.28 65.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.329 -0.85 . . . . 6.79 109.172 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ARG . . . . . 0.43 ' HG3' ' SG ' ' B' ' 77' ' ' CYS . 43.4 mtt-85 -95.54 134.77 38.01 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.77 0.319 . . . . 7.6 111.493 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' MET . . . . . 0.407 ' HG2' HG23 ' B' ' 28' ' ' VAL . 20.3 ptp -152.68 163.07 40.36 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.823 -0.436 . . . . 5.33 109.823 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -76.23 170.98 15.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.154 0.502 . . . . 4.5 111.581 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 9.9 ttm180 -66.33 -39.44 89.25 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.469 -0.787 . . . . 4.56 112.418 -179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 19.9 t -59.3 -57.37 11.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 111.888 0.329 . . . . 3.5 111.888 -178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' VAL . . . . . . . . . . . . . 97.8 t -58.99 -40.06 79.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.936 0.398 . . . . 3.92 110.81 -179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.448 ' NH2' ' HA ' ' B' ' 30' ' ' GLU . 35.7 ttm180 -59.23 -52.45 65.62 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.953 -0.567 . . . . 5.38 110.891 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -65.08 -36.89 85.76 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.935 -0.575 . . . . 3.95 111.439 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' ASN . . . . . 0.608 ' O ' ' HD3' ' B' ' 65' ' ' ARG . 2.7 m-20 -74.77 -17.22 60.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.529 -0.305 . . . . 3.87 111.038 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' LEU . . . . . . . . . . . . . 13.8 mt -90.3 -2.48 58.01 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 4.98 109.056 177.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 62.53 29.59 17.05 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 114.632 -1.167 . . . . 5.34 110.914 179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.54 156.05 17.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.043 -0.526 . . . . 5.68 110.262 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -122.14 -178.81 3.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.466 -0.333 . . . . 6.23 110.242 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -62.5 124.01 19.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.856 0.36 . . . . 7.06 110.671 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.01 5.43 59.63 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.54 -0.838 . . . . 7.69 112.402 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -89.58 163.94 14.98 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.945 -0.391 . . . . 7.07 109.945 179.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -112.89 131.98 62.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.183 0.516 . . . . 7.99 111.508 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ILE . . . . . . . . . . . . . 2.2 pp -122.09 167.62 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.552 -0.749 . . . . 6.77 110.106 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' SER . . . . . . . . . . . . . 14.9 m -116.52 127.36 54.46 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.467 -0.333 . . . . 6.9 110.646 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ILE . . . . . . . . . . . . . 11.9 tt -110.64 133.58 55.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.084 0.469 . . . . 6.26 110.853 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.99 124.38 5.43 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.043 -0.526 . . . . 6.23 110.429 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.78 135.27 55.09 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.422 2.081 . . . . 5.8 111.107 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' B' ' 106' ' ' PRO . 57.7 m -74.32 111.84 14.52 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 116.564 -0.289 . . . . 4.81 111.582 -178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' B' ' 105' ' ' CYS . 3.7 Cg_exo -74.08 -32.54 6.82 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.576 2.184 . . . . 4.57 111.646 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ASP . . . . . . . . . . . . . 62.4 m-20 -133.5 117.03 16.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.666 -0.697 . . . . 4.51 110.264 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -128.43 163.4 32.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 108.828 -0.804 . . . . 3.63 108.828 178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . 0.494 ' HA ' ' CA ' ' A' ' 14' ' ' GLY . 7.9 ptmt -144.1 156.59 44.41 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.435 -0.506 . . . . 5.34 111.405 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' TYR . . . . . 0.603 ' OH ' ' HB3' ' A' ' 10' ' ' GLN . 3.8 m-30 -79.81 143.28 34.55 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.453 -0.794 . . . . 3.24 110.423 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' GLY . . . . . . . . . . . . . . . -75.38 102.01 1.44 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.648 -0.787 . . . . 2.56 111.452 179.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -80.84 16.05 1.57 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.062 0.458 . . . . 5.53 110.706 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ARG . . . . . 0.408 ' HB3' ' HB2' ' B' ' 169' ' ' ASP . 14.0 ttm180 -170.73 128.07 0.77 Allowed 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.233 -1.025 . . . . 6.49 108.233 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' ILE . . . . . . . . . . . . . 48.5 mt -129.2 112.1 24.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.893 0.377 . . . . 2.9 110.29 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' HIS . . . . . 0.444 ' HB2' ' HG3' ' B' ' 167' ' ' GLU . 5.9 m170 -112.44 102.64 10.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.025 -0.534 . . . . 4.52 110.462 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' B' ' 165' ' ' VAL . 7.9 m -120.25 149.4 23.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.116 -0.493 . . . . 2.76 110.021 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LEU . . . . . . . . . . . . . 58.3 mt -138.15 141.31 31.64 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.597 0.237 . . . . 3.35 111.034 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -78.93 153.52 25.5 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.422 2.082 . . . . 2.85 111.508 178.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' ILE . . . . . . . . . . . . . 4.3 mt -82.9 146.06 7.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 110.169 -0.308 . . . . 2.46 110.169 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -57.09 -37.47 71.94 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.738 0.644 . . . . 2.98 112.738 -178.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' ASP . . . . . 0.42 ' HA ' ' OE2' ' B' ' 124' ' ' GLU . 2.0 p-10 -77.77 -17.77 57.16 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.091 0.404 . . . . 2.71 112.091 -178.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' THR . . . . . . . . . . . . . 9.9 p -91.89 -3.61 55.79 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.714 -0.394 . . . . 3.04 111.667 -179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 29.3 m -117.13 14.24 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.004 0.431 . . . . 3.94 111.485 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' GLU . . . . . 0.42 ' OE2' ' HA ' ' B' ' 121' ' ' ASP . 74.2 mt-10 -73.36 118.08 15.88 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.258 -0.428 . . . . 4.16 110.829 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLY . . . . . . . . . . . . . . . 99.14 -12.52 62.07 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.71 -0.757 . . . . 5.24 113.41 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' ILE . . . . . . . . . . . . . 36.0 pt -112.97 161.24 12.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 117.163 0.482 . . . . 4.89 111.132 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' THR . . . . . . . . . . . . . 15.2 t -162.29 154.98 19.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.014 -0.539 . . . . 5.89 109.917 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLY . . . . . . . . . . . . . . . 124.68 -134.49 9.05 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.472 -0.87 . . . . 5.44 112.633 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -116.29 119.22 35.02 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.82 0.343 . . . . 5.15 110.731 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' LEU . . . . . . . . . . . . . 89.3 mt -105.67 -9.37 17.36 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.19 0.519 . . . . 4.59 110.041 179.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' PHE . . . . . 0.509 ' HA ' ' HB2' ' B' ' 135' ' ' LEU . 56.7 t80 -64.77 -52.98 54.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.59 -0.732 . . . . 5.12 111.44 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -77.5 -7.71 56.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.249 -0.432 . . . . 5.33 112.099 -178.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.76 -34.5 2.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 112.867 0.692 . . . . 4.94 112.867 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -125.35 -49.53 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.062 0.764 . . . . 4.31 113.062 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' LEU . . . . . 0.509 ' HB2' ' HA ' ' B' ' 131' ' ' PHE . 1.9 mm? -79.28 48.57 0.89 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.026 0.441 . . . . 2.8 111.853 -178.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' LYS . . . . . 0.406 ' CB ' ' HD3' ' B' ' 137' ' ' PRO . 13.5 tttt -157.08 -57.25 0.02 OUTLIER Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.052 -0.522 . . . . 4.72 111.002 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' PRO . . . . . 0.406 ' HD3' ' CB ' ' B' ' 136' ' ' LYS . 24.0 Cg_exo -65.09 -19.5 63.29 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.171 1.914 . . . . 3.84 112.271 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -89.13 -5.6 57.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.257 -0.428 . . . . 2.93 110.706 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -114.36 -42.01 3.38 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.133 0.492 . . . . 2.22 110.42 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' LEU . . . . . 0.561 ' O ' ' HG2' ' B' ' 141' ' ' GLU . 29.0 tp -62.07 123.3 17.75 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.696 -0.684 . . . . 4.03 110.576 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' GLU . . . . . 0.561 ' HG2' ' O ' ' B' ' 140' ' ' LEU . 5.2 pt-20 62.06 9.92 3.38 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.919 0.888 . . . . 4.06 112.691 179.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.11 -54.9 6.35 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.718 -0.219 . . . . 2.43 111.198 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' TYR . . . . . . . . . . . . . 8.6 m-85 57.72 60.48 2.78 Favored 'General case' 0 N--CA 1.463 0.201 0 O-C-N 123.557 0.536 . . . . 2.73 111.296 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' ARG . . . . . . . . . . . . . 13.2 mtt180 -120.15 146.66 42.95 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.876 -0.602 . . . . 3.04 110.457 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' PRO . . . . . 0.435 ' HB2' ' HB ' ' B' ' 68' ' ' VAL . 98.1 Cg_endo -82.45 136.42 8.69 Favored 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.574 2.183 . . . . 2.28 111.925 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' ILE . . . . . . . . . . . . . 19.8 pt -138.61 150.67 23.95 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.904 0.383 . . . . 2.17 111.276 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' B' ' 172' ' ' PRO . 0.3 OUTLIER -119.37 154.58 33.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.094 -0.503 . . . . 4.21 109.66 178.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -61.03 122.44 14.97 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.406 -0.361 . . . . 3.82 111.013 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.88 1.86 58.5 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.941 -0.647 . . . . 2.52 113.139 179.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' ASP . . . . . 0.496 ' HA ' ' ND2' ' B' ' 91' ' ' ASN . 65.2 m-20 -82.1 150.56 27.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 117.138 0.469 . . . . 2.52 110.425 -179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ILE . . . . . . . . . . . . . 72.1 mt -119.64 129.68 75.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.171 -0.468 . . . . 1.65 109.879 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -120.9 149.63 42.32 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.875 0.369 . . . . 1.32 110.391 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' LEU . . . . . . . . . . . . . 30.5 tp -108.31 129.39 55.23 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.001 -0.545 . . . . 2.62 110.719 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' B' ' 160' ' ' ALA . 88.8 t -98.51 100.12 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 N-CA-C 109.507 -0.553 . . . . 2.85 109.507 178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -90.94 -31.48 16.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.215 -0.448 . . . . 4.82 110.286 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLY . . . . . . . . . . . . . . . -82.93 66.27 3.97 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.953 -0.641 . . . . 4.7 112.055 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' GLY . . . . . 0.448 ' O ' ' HB2' ' B' ' 158' ' ' MET . . . -172.18 46.98 0.18 Allowed Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.629 -0.588 . . . . 4.71 111.629 179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' B' ' 157' ' ' GLY . 54.2 mtt 71.62 -64.97 0.37 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.211 0.605 . . . . 7.05 111.241 -179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' ARG . . . . . . . . . . . . . 10.5 ptp180 -114.16 147.25 39.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.39 -0.368 . . . . 5.18 110.27 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 154' ' ' VAL . . . -83.59 100.37 10.77 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.28 -0.418 . . . . 3.42 110.238 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 2.7 t -102.24 141.72 17.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.303 -0.408 . . . . 3.01 110.928 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -97.31 128.17 43.91 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.806 -0.634 . . . . 1.89 110.271 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.31 137.16 54.06 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 110.079 -0.341 . . . . 2.57 110.079 179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' LYS . . . . . 0.425 ' HB3' HD11 ' B' ' 189' ' ' ILE . 83.4 tttt -109.37 132.44 54.12 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.45 . . . . 2.59 111.227 -178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' VAL . . . . . 0.452 ' HA ' HG12 ' B' ' 116' ' ' VAL . 52.2 t -80.35 107.61 12.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.852 -0.613 . . . . 2.34 109.809 179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' VAL . . . . . . . . . . . . . 39.5 t -68.82 -51.69 42.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.133 -0.485 . . . . 3.3 110.463 -179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' GLU . . . . . 0.444 ' HG3' ' HB2' ' B' ' 115' ' ' HIS . 0.0 OUTLIER -172.78 166.88 5.31 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 4.29 110.936 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' THR . . . . . . . . . . . . . 2.1 p -132.93 -179.02 5.22 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.703 -0.68 . . . . 3.69 109.507 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' ASP . . . . . 0.617 ' HB3' ' HD3' ' B' ' 170' ' ' PRO . 20.2 t70 -64.97 -55.68 25.8 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 120.849 -0.34 . . . . 4.27 110.593 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' PRO . . . . . 0.617 ' HD3' ' HB3' ' B' ' 169' ' ' ASP . 4.0 Cg_endo -91.64 130.22 1.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.534 2.156 . . . . 3.68 111.414 178.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' SER . . . . . . . . . . . . . 3.1 m -98.66 146.41 31.57 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 116.263 -0.426 . . . . 4.28 110.384 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' PRO . . . . . 0.482 ' O ' ' HG2' ' B' ' 147' ' ' ARG . 73.3 Cg_endo -99.1 7.37 28.32 Favored 'Cis proline' 0 N--CA 1.456 -0.732 0 C-N-CA 123.895 -1.294 . . . . 4.25 113.081 -0.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' TYR . . . . . . . . . . . . . 34.8 p90 -152.15 167.48 28.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 120.527 0.204 . . . . 4.44 111.229 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' CYS . . . . . 0.435 ' HB3' ' HG2' ' B' ' 170' ' ' PRO . 29.2 p -172.68 179.43 2.41 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.99 -0.55 . . . . 2.5 110.265 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 15' ' ' VAL . 75.0 mt -102.07 136.86 32.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.948 -0.39 . . . . 2.17 109.948 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' VAL . . . . . . . . . . . . . 43.0 t -59.19 114.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.136 -0.484 . . . . 1.69 110.979 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' ALA . . . . . . . . . . . . . . . -97.52 111.01 57.37 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.675 -0.693 . . . . 2.14 109.508 178.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' PRO . . . . . 0.417 ' HB3' ' H ' ' B' ' 141' ' ' GLU . 49.4 Cg_endo -68.64 -12.31 34.32 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.631 2.22 . . . . 2.78 112.401 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -86.52 -13.01 47.23 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.756 -0.656 . . . . 3.27 110.503 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' THR . . . . . . . . . . . . . 33.3 m -90.89 143.88 26.26 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 3.08 110.387 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' VAL . . . . . . . . . . . . . 19.7 t -80.09 112.01 17.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.714 0.292 . . . . 3.77 110.55 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ILE . . . . . . . . . . . . . 1.8 mt -69.04 141.97 16.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 109.48 -0.563 . . . . 3.44 109.48 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' HIS . . . . . . . . . . . . . 2.4 m170 -122.95 121.53 36.36 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.154 0.502 . . . . 4.91 111.086 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' CYS . . . . . . . . . . . . . 5.6 t -126.32 106.59 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.721 -0.672 . . . . 4.11 110.066 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -66.09 153.02 43.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.046 -0.525 . . . . 4.82 110.146 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' GLY . . . . . . . . . . . . . . . -85.31 53.46 4.77 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.797 -0.716 . . . . 4.76 112.063 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -146.05 104.27 4.13 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 110.154 -0.313 . . . . 5.14 110.154 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -63.5 149.53 90.83 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 122.748 2.299 . . . . 3.89 111.91 179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' ILE . . . . . 0.425 HD11 ' HB3' ' B' ' 164' ' ' LYS . 11.6 pt -108.5 154.86 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.745 0.307 . . . . 3.06 111.152 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' LYS . . . . . . . . . . . . . 23.4 pttt -84.32 154.47 22.89 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.043 -0.526 . . . . 4.07 110.156 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' ARG . . . . . 0.611 ' NH1' ' HA ' ' B' ' 197' ' ' SER . 27.4 ttm-85 -88.43 144.99 26.03 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.246 -0.433 . . . . 2.34 110.727 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 61.1 mm-40 -83.78 166.11 18.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.436 -0.347 . . . . 3.41 110.282 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -72.92 -36.55 67.27 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.037 0.384 . . . . 3.43 112.037 -178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -79.88 -5.89 56.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.873 0.368 . . . . 3.83 111.418 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -104.31 108.99 20.66 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.346 -0.388 . . . . 2.52 110.189 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -78.24 168.51 19.74 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.195 -0.457 . . . . 3.42 110.876 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' SER . . . . . 0.611 ' HA ' ' NH1' ' B' ' 191' ' ' ARG . 43.3 t -96.34 138.93 33.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.028 -0.533 . . . . 2.46 110.046 179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.77 0.35 13.34 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.115 0.483 . . . . 2.93 110.418 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -87.21 -8.25 57.06 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.98 -0.748 . . . . 3.37 108.98 177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -65.33 152.73 43.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.379 -0.828 . . . . 3.61 110.352 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' VAL . . . . . . . . . . . . . 46.4 t -82.97 106.67 13.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-O 121.078 0.466 . . . . 4.76 110.501 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' GLY . . . . . . . . . . . . . . . -103.5 -157.88 24.77 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.873 -0.68 . . . . 5.02 111.529 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -77.06 -24.52 51.95 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.092 0.473 . . . . 5.97 110.137 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -78.13 -7.99 57.7 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.744 -0.662 . . . . 5.39 110.956 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -93.5 0.09 56.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.169 0.509 . . . . 5.73 110.265 179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' VAL . . . . . . . . . . . . . 57.5 t -106.67 121.77 59.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.808 -0.633 . . . . 6.63 109.692 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' GLY . . . . . . . . . . . . . . . -112.5 143.72 17.69 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.79 -0.719 . . . . 7.52 112.349 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' GLY . . . . . . . . . . . . . . . 82.06 -55.46 4.92 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 121.224 -0.513 . . . . 8.4 112.558 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' CYS . . . . . . . . . . . . . 5.9 m -69.16 97.01 0.87 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.867 0.365 . . . . 7.96 110.789 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' ARG . . . . . . . . . . . . . 83.3 mtt85 -109.03 -55.68 2.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.229 0.537 . . . . 8.91 110.34 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -79.48 -2.67 43.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.568 -0.742 . . . . 9.47 110.303 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLN . . . . . . . . . . . . . 29.5 mm-40 -90.85 2.95 55.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.493 -0.776 . . . . 9.37 109.571 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-N 115.321 -0.854 . . . . 7.87 109.472 179.526 . . . . . . . . 0 0 . 1 stop_ save_